EBV-positive Lymphoproliferative Disease With Medullary, Splenic and Hepatic Infiltration After Imatinib Mesylate Therapy for Chronic Myeloid Leukemia

Leukemia. 2007 Oct;21(10):2208-10. doi: 10.1038/sj.leu.2404758. Epub 2007 May 31.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Benzamides
  • Cell Proliferation
  • Female
  • Herpesvirus 4, Human / metabolism*
  • Humans
  • Imatinib Mesylate
  • In Situ Hybridization, Fluorescence
  • Kidney Medulla / virology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology*
  • Liver / virology*
  • Lymphoproliferative Disorders / chemically induced
  • Lymphoproliferative Disorders / metabolism
  • Lymphoproliferative Disorders / virology*
  • Middle Aged
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*
  • Recurrence
  • Spleen / virology*
  • Translocation, Genetic

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate